{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Back to Basics: Lentigo Maligna

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of the pathogenesis, diagnosis, and treatment of lentigo maligna (LM) by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $1.50

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH
  • NM - BON 1.5 CH
  • SC - BON 1.5 CH
  • WV - BOERN 1.5 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: JDNA0923
Published: Sep/Oct 2023
Expires: 9/5/2025
Required Passing Score: 7/10 (70%)
Authors: Kabir Quazi Al-Tariq, MS